Search
for
Sort by
Research 871–900 of 1000+
- HAIR AND SYSTEMATIC DISEASE
- Pharmacology and Pharmacokinetics of Minoxidil
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants
- Hair disorders in patients with cancer
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- DISORDERS OF THE NAILS AND HAIR ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
- Minoxidil
- Effects of Fetal Exposure to Diazoxide in Man
- Drug-Induced Hair Disorders
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Animal models of androgen-dependent disorders of the pilosebaceous apparatus
- Treatment of monilethrix with oral minoxidil
- Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations
- Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C’s of oral therapy
- Drug-induced hair colour changes
- Management of severe childhood hypertension with minoxidil: A controlled clinical study
- Characterization of an<i>in vivo</i>model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost
- Direct Vasodilators and Sympatholytic Agents
- Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes
- TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.
- Disorders of hair growth : diagnosis and treatment
- A Comparison of Minoxidil and Hydralazine in Non-azotemic Hypertensives
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Acquired trichomegaly with topiramate
- Ovarian function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisone combination regimens
- Female Adolescent Hair Disorders
- Does Cyclosporin A Influence Sex Hormone Level?
- Cyclosporine
- Low‐dose oral minoxidil as treatment for non‐scarring alopecia: a systematic review
- An osteopontin‐derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor‐7 production in outer root sheath keratinocytes